HIV/AIDS News

  • The Year in Medicine 2017: News That Made a Difference Read the medical news that got the most attention this year, including multiple hurricanes, the effort to repeal the Affordable Care Act, the opioid crisis (again), and much more.
 
  • Alert HIV Drug Raltegravir Approved for Neonates Raltegravir is the only integrase inhibitor approved in the US for treatment of HIV in newborns from birth to 4 weeks of age weighing at least 2 kg.
  • Statins, Aspirin Grossly Underused in HIV: US Study There could be many reasons too few with indications are getting the drugs, including but not limited to poor cross-specialty communication and the changing needs of an aging HIV population.
 

Today on Medscape

Top Stories from Across Medicine

Top Medical News from Across Medscape

  • Omalizumab May Help Desensitization for Food AllergiesA pilot study suggests omalizumab may improve speed, effectiveness, and safety of oral desensitization in children with multiple food allergies; more research is needed to see if effect lasts.
  • AI Ups Precision in Breast Cancer PathologyIn a challenge of diagnostic accuracy and precision in metastatic breast cancer, artificial intelligence (AI) outperformed pathologists at reviewing and interpreting whole-slide images.
  • Psychotherapy May Up Buprenorphine AdherencePsychotherapy as an adjunct to buprenorphine maintenance treatment significantly improves long-term treatment retention rates compared with standard counseling provided by prescribing physicians.

Perspective

Business of Medicine

Columnists

Advisory Board

 

Site Editorial Director

Medscape Editor-in-Chief

  • Eric J. Topol, MD Eric J. Topol, MD Director, Scripps Translational Science Institute; Executive Vice President and Professor of Molecular Medicine, The Scripps Research Institute; Senior Consultant, Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California; Editor-in-Chief, Medscape